Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Keiko, Higuchi"'
Autor:
Nupur Greene, Stéphane Quéré, Denise P. Bury, Flora Mazerolle, Manal M’Hari, Angély Loubert, Antoine Regnault, Keiko Higuchi
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-14 (2023)
Abstract Background As disease-modifying therapies do not reverse the course of multiple sclerosis (MS), assessment of therapeutic success involves documenting patient-reported outcomes (PROs) concerning health-related quality of life, disease and tr
Externí odkaz:
https://doaj.org/article/94182c688a5c44198acf541402a0d875
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 1 (2022)
Aim: Describe demographics, clinical characteristics, healthcare resource utilization (HCRU) and costs in people with multiple sclerosis (pwMS) switching to alemtuzumab from other disease-modifying therapies (DMTs). Patients & methods: Retrospectiv
Externí odkaz:
https://doaj.org/article/a9395ad0d04741748bedca1d6f06478a
Autor:
Toshio Nishikawa, Yoshiki Ono, Keiko Higuchi, Masashi Yamaguchi, Kumi Sugino, Atsuo Nakazaki, Masaatsu Adachi
Publikováno v:
Synlett. 34:364-368
A new strategy for the convergent synthesis of the ABCD ring system of indole terpene alkaloids has been developed based on a Sonogashira coupling of an o-iodoaniline (the A ring) with an alkyne bearing the D ring. After a tandem palladium-catalyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c67803c40093bf5023d938de77bf5456
https://doi.org/10.1055/s-0042-1751396
https://doi.org/10.1055/s-0042-1751396
Publikováno v:
ClinicoEconomics and Outcomes Research. 14:755-761
Nupur Greene,1 Keiko Higuchi,1 Katalin Bognar,2 Eunice Chang,2 Michael S Broder2 1Neurology & Immunology (N&I), Sanofi, Cambridge, MA, USA; 2Real World Evidence, PHAR (Partnership for Health Analytic Research), Beverly Hills, CA, USACorrespondence: N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9a77a13b3d5ce8b3a76cea8531caeb8
https://doi.org/10.2147/ceor.s383934
https://doi.org/10.2147/ceor.s383934
Publikováno v:
ClinicoEconomics and Outcomes Research.
Lita Araujo,1 Srikanth Kyatham,2 Kristen G Bzdek,1 Keiko Higuchi,1 Nupur Greene1 1Neurology and Immunology, Sanofi, Cambridge, MA, USA; 2Axtria Inc, Berkeley Heights, NJ, USACorrespondence: Lita Araujo, Neurology and Immunology, Sanofi, 450 Water Str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81829cb274f4b27a5f3b3dc5a0fdafbe
https://www.dovepress.com/assessing-the-health-economic-outcomes-from-commercially-insured-relap-peer-reviewed-fulltext-article-CEOR
https://www.dovepress.com/assessing-the-health-economic-outcomes-from-commercially-insured-relap-peer-reviewed-fulltext-article-CEOR
Autor:
Gauruv Bose, Nupur Greene, Brian C. Healy, Howard Weiner, Lisa Farnett, Keiko Higuchi, Tanuja Chitnis
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e95959c5b44dcbe4187ab99b2ce77ea3
https://doi.org/10.1212/wnl.0000000000202901
https://doi.org/10.1212/wnl.0000000000202901
Publikováno v:
Neurology and therapy. 11(4)
Therapeutic efficacy of disease-modifying therapies (DMTs) for multiple sclerosis (MS) is often hindered by poor persistence and adherence, impacted by patient-perceived efficacy concerns, adverse effects, inconvenience, and forgetfulness. This study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d031e184b3f1cdf6d6ed0444c0bebf0
https://pubmed.ncbi.nlm.nih.gov/36152222
https://pubmed.ncbi.nlm.nih.gov/36152222
Autor:
Ishikawa, Hitoshi, Keiko Higuchi, Kaminuma, Takuya, Takezawa, Yutaka, Saito, Yoshitaka, Toru Etsunaga, Kazushi Maruo, Kawamura, Hidemasa, Kubo, Nobuteru, Nakano, Takashi, Mikio Kobayashi, Hitoshi, Ishikawa, Hidemasa, Kawamura, Nobuteru, Kubo, Takashi, Nakano
Publikováno v:
Journal of Radiation Research. 61(6):908-919
The feasibility and efficacy of hypofractionated salvage radiotherapy (HS-RT) for prostate cancer (PC) with biochemical recurrence (BR) after prostatectomy, and the usefulness of prostate-specific antigen (PSA) kinetics as a predictor of BR, were eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::16f3923d563e2de98036c307369233e7
https://repo.qst.go.jp/records/81181
https://repo.qst.go.jp/records/81181
Autor:
Deepak L. Bhatt, Andrew H. Briggs, Shelby D. Reed, Lieven Annemans, Michael Szarek, Vera A. Bittner, Rafael Diaz, Shaun G. Goodman, Robert A. Harrington, Keiko Higuchi, Florence Joulain, J. Wouter Jukema, Qian H. Li, Kenneth W. Mahaffey, Robert J. Sanchez, Matthew T. Roe, Renato D. Lopes, Harvey D. White, Andreas M. Zeiher, Gregory G. Schwartz, Ph. Gabriel Steg, Pierluigi Tricoci, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean-François Tamby
Publikováno v:
Journal of the American College of Cardiology. 75:2297-2308
Background Cholesterol reduction with proprotein convertase subtilisin-kexin type 9 inhibitors reduces ischemic events; however, the cost-effectiveness in statin-treated patients with recent acute coronary syndrome remains uncertain. Objectives This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d4f2656359a514cb6fbc8ea45fa10d2
https://doi.org/10.1016/j.jacc.2020.03.029
https://doi.org/10.1016/j.jacc.2020.03.029
Autor:
Jonathan Silverberg, Julia S. Lehman, Animesh A. Sinha, Yola Moride, Keiko Higuchi, Kerri Ford, Philip Sugerman, Ekaterina Smolkina
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f5742a4a00d70dc4039abcfd503c6f9
https://doi.org/10.1016/j.jaad.2022.06.630
https://doi.org/10.1016/j.jaad.2022.06.630